scholarly journals Mechanisms of Development of Hemostatic Disorders after Liver Resection

2010 ◽  
Vol 6 (3) ◽  
pp. 61
Author(s):  
S. A. Shaposhnikov ◽  
S. V. Sinkov ◽  
K. F. Ivanov ◽  
I. B. Zabolotskikh
Author(s):  
В. Желобов ◽  
А. Туев ◽  
А. Агафонов

Введение. Нарушения со стороны системы гемостаза при заболеваниях кроветворных органов чрезвычайно разнообразны как по механизмам развития, так и по клиническим проявлениям. Цель исследования. Изучение причин гемостазиологических расстройств при различных патогенетических вариантах анемических состояний. Материалы и методы. Показатели коагуляционного гемостаза, липидной пероксидации и эндотелий-зависимая вазодилатация исследованы у 30 больных железодефицитной анемией, 22 больных витамин В12-дефицитной анемией и 18 больных апластической анемией. Результаты. Гемическая гипоксия, присущая анемии, сопровождается активацией свободно-радикального окисления липидов — увеличением концентрации малонового диальдегида плазмы и уменьшением антиокислительного потенциала крови. Оксидативный стресс приводит к системному поражению эндотелия, проявляющегося снижением релаксирующих свойств эндотелия сосудов и активацией системы гемостаза, представленной гипокоагуляцией по внутреннему механизму, угнетением плазминовой системы и увеличением концентрации растворимых фибрин-мономерных комплексов. Заключение. Развитие анемии, независимо от ее патогенетического механизма, сопровождается развитием метаболического дисбаланса, дисфункцией эндотелия, что в конечном итоге приводит к нарушениям со стороны коагуляционного гемостаза. Introduction. Hemostasis disturbances in diseases of hematopoietic organs are considerably varied both in mechanisms of development, and in clinical manifestations. The aim: to study the causes of hemostatic disorders at various pathogenetic types of anemias. Materials and methods. In 30 patients with iron defi ciency anemia, in 22 patients with vitamin B12-deficiency anemia and in 18 patients with aplastic anemia parameters of coagulative hemostasis, lipid peroxidation, and endothelium-dependent vasodilation were studied. Results. Attributable to anemia hemic hypoxia is accompanied by activation of free-radical lipids oxidation — increasing concentration of plasma malone dialdehyde and decreasing of blood antioxidant potential. Oxidative stress leads to systemic damage of endothelium that manifested by decreasing of vascular endothelial relaxing properties and hemostasis activation: internal mechanism of hypocoagulation, inhibition of plasmin system and increasing concentration of soluble fibrin monomer complexes. Conclusion. Anemia progression regardless of its pathogenic mechanism is associated with the development of metabolic disbalance, endothelial dysfunction that fi nally leads to disturbances of coagulative hemostasis.


2018 ◽  
Vol 14 (5) ◽  
pp. 58-84 ◽  
Author(s):  
V. I. Reshetnyak ◽  
S. V. Zhuravel ◽  
N. K. Kuznetsova ◽  
V. М. Pisarev ◽  
E. V. Klychnikova ◽  
...  

The review dwells on the problem of hemostatic disorders in patients undergoing liver transplantation and their correction in the perioperative period. The physiology of the hemostatic system, disorders of the blood coagulation system in patients at various stages of liver transplantation, correction of hemostatic disorders during and after orthotopic liver transplantation are discussed. Liver transplantation is performed in patients with liver diseases in the terminal stage of liver failure. At the same time, changes in the hemostatic system of these patients pose a significant risk of developing bleeding and/or thrombosis during and after liver transplantation. The hypothesis is suggested that the personalized correction of hemostasis disorder in liver transplantation should be based on considerating the nosological forms of the liver damage, mechanisms of development of recipient’s hemostatic disorders, and the stage of the surgery.


Swiss Surgery ◽  
2000 ◽  
Vol 6 (4) ◽  
pp. 164-168 ◽  
Author(s):  
Seiler ◽  
Redaelli ◽  
Schmied ◽  
Baer ◽  
Büchler

Neue Erkenntnisse über die Anatomie und Funktion der Leber haben dazu geführt, dass heute die chirurgische Resektion die Therapie der Wahl bei Lebermetastasen geworden ist. Obschon Lebermetastasen ein fortgeschrittenes Tumorstadium bedeuten, werden infolge besserer Kenntnisse der Karzinogenese (Mikrometastasen etc.) sowie der prognostischen Risikofaktoren erwiesenermassen die besten Langzeitresultate durch die chirurgische Resektion erzielt. In dieser Studie wurden die Ergebnisse von 109 Resektionen von kolorektalen sowie nicht kolorektalen Lebermetastasen an unserer Klinik während eines Zeitraumes von 59 Monaten zusammengefasst. Vier verschiedene Operationsverfahren (formelle Hemihepatektomie vs Segmentresektion vs atypische Resektion vs Biopsie) wurden untersucht. Die Einhaltung eines Resektionsabstandes von mindestens 10 mm wurde bei Resektionen immer angestrebt. Die kumulierte Morbidität aller Operationsverfahren zusammen betrug 23%. Obwohl die Morbidität bei ausgedehnten Resektionen höher war (Encephalopathie 16% vs 2.3% bei der Segmentresektion, Leberinsuffizienz 23% vs 4.7%), war das Langzeitüberleben gegenüber den limitierten Resektionsverfahren verbessert. Die 60-Tage Mortalität lag bei 2.7%. Patienten nach Resektion von kolorektalen Lebermetastasen hatten eine höhere Ueberlebensrate als diejenigen nach Resektion nicht kolorektaler Metastasen. Unsere Resultate zeigen, dass die Leberresektion heutzutage unter Einhaltung der anatomischen sowie funktionellen Grenzen (inkl. eines adäquaten Resektionsrandes) die einzige, potentiell kurative Therapie von Lebermetastasen darstellt. Trotz erhöhter perioperativer Morbidität ist die ausgedehnte formelle Resektion den limitierten Operationsverfahren bezüglich Langzeitüberleben überlegen. Ein Grund dafür ist die erhöhte Wahrscheinlichkeit einer Mitresektion von präoperativ nicht detektierbaren lokalen Mikrometastasen.


1987 ◽  
Vol 57 (01) ◽  
pp. 118-122 ◽  
Author(s):  
C Thomas Kisker

SummaryAnimal models have added significantly to our understanding of adult hemorrhagic and thrombotic diseases. Few models, however, have been developed for studies of the hemostatic disorders in the fetus and newborn. This report reviews the current information on animal models of fetal and neonatal hemostasis. The requirements of a relevant model are addressed and previous studies using fetal and neonatal animal models are reviewed. A recommendation of a single animal for all studies of fetal and neonatal hemostasis is not possible. However, the lamb has been the most frequently studied and appears to provide relevant information regarding normal development and the factors which may adversely influence hemostasis in the fetus and newborn.


1982 ◽  
Vol 48 (03) ◽  
pp. 277-282 ◽  
Author(s):  
I Nathan ◽  
A Dvilansky ◽  
T Yirmiyahu ◽  
M Aharon ◽  
A Livne

SummaryEchis colorata bites cause impairment of platelet aggregation and hemostatic disorders. The mechanism by which the snake venom inhibits platelet aggregation was studied. Upon fractionation, aggregation impairment activity and L-amino acid oxidase activity were similarly separated from the crude venom, unlike other venom enzymes. Preparations of L-amino acid oxidase from E.colorata and from Crotalus adamanteus replaced effectively the crude E.colorata venom in impairment of platelet aggregation. Furthermore, different treatments known to inhibit L-amino acid oxidase reduced in parallel the oxidase activity and the impairment potency of both the venom and the enzyme preparation. H2O2 mimicked characteristically the impairment effects of L-amino acid oxidase and the venom. Catalase completely abolished the impairment effects of the enzyme and the venom. It is concluded that hydrogen peroxide formed by the venom L-amino acid oxidase plays a role in affecting platelet aggregation and thus could contribute to the extended bleeding typical to persons bitten by E.colorata.


2019 ◽  
Vol 98 (10) ◽  

Introduction: Radical liver resection is the only method for the treatment of patients with colorectal liver metastases (CLM); however, only 20–30% of patients with CLMs can be radically treated. Radiofrequency ablation (RFA) is one of the possible methods of palliative treatment in such patients. Methods: RFA was performed in 381 patients with CLMs between 01 Jan 2001 and 31 Dec 2018. The mean age of the patients was 65.2±8.7 years. The male to female ratio was 2:1. Open laparotomy was done in 238 (62.5%) patients and the CT-navigated transcutaneous approach was used in 143 (37.5%) patients. CLMs <5 cm (usually <3 cm) in diameter were the indication for RFA. We used RFA as the only method in 334 (87.6%) patients; RFA in combination with resection was used in 36 (9.4%), and with multi-stage resection in 11 (3%) patients. We performed RFA in a solitary CLM in 170 (44.6%) patients, and in 2−5 CLMs in 211 (55.6%) patients. We performed computed tomography in each patient 48 hours after procedure. Results: The 30-day postoperative mortality was zero. Complications were present in 4.8% of transcutaneous and in 14.2% of open procedures, respectively, in the 30-day postoperative period. One-, 3-, 5- and 10-year overall survival rates were 94.8, 66.8, 43.9 and 16.6%, respectively, in patients undergoing RFA, and 90.6, 69.1, 52.8 and 39.2%, respectively, in patients with liver resections. Disease free survival was 63.2, 30.1, 18.4 and 13.1%, respectively, in the same patients after RFA, and 71.1, 33.3, 22.8 and 15.5%, respectively, after liver resections. Conclusion: RFA is a palliative thermal ablation method, which is one of therapeutic options in patients with radically non-resectable CLMs. RFA is useful especially in a non-resectable, or resectable (but for the price of large liver resection) solitary CLM <3 cm in diameter and in CLM relapses. RFA is also part of multi-stage liver procedures.


2010 ◽  
Vol 28 ◽  
pp. 47-51 ◽  
Author(s):  
Takatoshi Ishiko ◽  
Toru Beppu ◽  
Akira Chikamoto ◽  
Toshiro Masuda ◽  
Hirohisa Okabe ◽  
...  

2016 ◽  
pp. 10-18 ◽  
Author(s):  
I.B. Vovk ◽  
◽  
N.Е. Gorban ◽  
O.Ju. Borysiuk ◽  
◽  
...  

In clinical lecture presents modern views of endometrial hyperplasia in terms of practitioner gynecologist. The problems of classification, pathogenetic mechanisms of development of endometrial hyperplasia. Particular attention is paid to modern approaches to diagnosis and treatment of endometrial hyperplasia. Key words: hyperplasia, endometrium, classification, endometrial hyperplasia, endometrial intraepithelial neoplasia, hormonal therapy.


Sign in / Sign up

Export Citation Format

Share Document